Antagonists of growth hormone-releasing hormone inhibit the growth of various experimental cancers including prostate, breast, ovarian, colorectal, lung, renal, endometrial cancers; glioblastomas and lymphomas (16, 17). The gene discussed is GHRH; the disease is glioblastoma.